MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2221.95%
Quick Ratio
2219.82%
Cash Ratio
41.57%
Debt to Asset Ratio
5.21%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Prepaid expenses and other curre...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
19,636
33,700
32,490
45,145
Marketable securities
1,008,642
1,042,542
709,665
635,118
Inventory
1,003
1,493
1,565
1,501
Accounts receivable, net
417
1,275
688
515
Prepaid expenses and other current assets
19,949
23,133
15,067
13,511
Total current assets
1,049,647
1,102,143
759,475
695,790
Total property and equipment, cost
17,835
17,368
17,070
15,952
Less accumulated depreciation
3,128
2,294
1,474
623
Property and equipment, net
14,707
15,074
15,596
15,329
Operating lease right-of-use assets
5,730
4,512
3,971
4,203
Intangible assets, net
545
560
575
1,672
Goodwill
10,297
10,297
10,297
12,805
Other assets
4,729
2,676
1,678
114
Total assets
1,085,655
1,135,262
791,592
729,913
Accounts payable
12,727
8,236
5,714
9,193
Operating lease liabilities, current portion
985
1,066
915
912
Accrued expenses and other current liabilities
33,528
25,914
24,207
20,423
Total current liabilities
47,240
35,216
30,836
30,528
Long-term debt
3,000
3,000
3,000
3,000
Operating lease liabilities, net of current portion
4,834
3,509
3,106
3,329
Deferred tax liability
307
307
307
1,609
Other liabilities
1,156
1,451
1,741
3,804
Total liabilities
56,537
43,483
38,990
42,270
Common stock, 0.0001 par value per share 700,000,000 and 700,000,000 share authorized as of june 30, 2026 and december 31, 2025, respectively 88,306,390 and 80,689,128 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
9
9
8
8
Additional paid-in capital
1,547,343
1,530,948
1,131,570
1,025,302
Accumulated deficit
-518,234
-439,178
-378,976
-337,667
Total stockholders' equity
1,029,118
1,091,779
752,602
687,643
Total liabilities and stockholders' equity
1,085,655
1,135,262
791,592
729,913
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$1,008,642K (56.03%↑ Y/Y)Prepaid expenses andother current assets$19,949K (74.75%↑ Y/Y)Cash and cashequivalents$19,636K (34.27%↑ Y/Y)Inventory$1,003K Accounts receivable, net$417K Total property andequipment, cost$17,835K Total current assets$1,049,647K (55.96%↑ Y/Y)Property and equipment,net$14,707K (5713.04%↑ Y/Y)Goodwill$10,297K Operating leaseright-of-use assets$5,730K (493.78%↑ Y/Y)Other assets$4,729K (805.94%↑ Y/Y)Intangible assets, net$545K Less accumulateddepreciation$3,128K Total assets$1,085,655K (54.77%↑ Y/Y)Total liabilities andstockholders' equity$1,085,655K (54.77%↑ Y/Y)Total stockholders'equity$1,029,118K (53.52%↑ Y/Y)Total liabilities$56,537K (81.87%↑ Y/Y)Accumulated deficit-$518,234K (-76.35%↓ Y/Y)Additional paid-in capital$1,547,343K (60.48%↑ Y/Y)Total currentliabilities$47,240K (55.49%↑ Y/Y)Operating leaseliabilities, net of current...$4,834K (584.70%↑ Y/Y)Long-term debt$3,000K Other liabilities$1,156K Deferred tax liability$307K Common stock, 0.0001par value per share...$9K (12.50%↑ Y/Y)Accrued expenses andother current...$33,528K (45.98%↑ Y/Y)Accounts payable$12,727K (78.62%↑ Y/Y)Operating leaseliabilities, current portion$985K (242.01%↑ Y/Y)

CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON)